|
Volumn 375, Issue 9732, 2010, Pages 2140-2141
|
Statins and risk of incident diabetes
a
Medical Service
(Italy)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PRAVASTATIN;
ROSUVASTATIN;
HYPOCHOLESTEROLEMIC AGENT;
CHOLESTEROL;
CLINICAL TRIAL;
DIABETES MELLITUS;
DYSLIPIDEMIA;
GLUCOSE BLOOD LEVEL;
GLUCOSE INTOLERANCE;
HEART FAILURE;
HEART PROTECTION;
HUMAN;
HYPERGLYCEMIA;
INSULIN RESISTANCE;
LETTER;
POSTMENOPAUSE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
META ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
RISK FACTOR;
DRUG EFFECT;
PANCREAS ISLET;
FEMALE;
MALE;
RISK ASSESSMENT;
SEX DIFFERENCE;
ANTICHOLESTEREMIC AGENTS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERGLYCEMIA;
META-ANALYSIS AS TOPIC;
RISK FACTORS;
CHOLESTEROL;
ISLETS OF LANGERHANS;
FEMALE;
MALE;
RISK ASSESSMENT;
SEX FACTORS;
|
EID: 77953675062
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)60990-7 Document Type: Letter |
Times cited : (4)
|
References (5)
|